We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$110B
AUM Growth
+$11.3B
(+11%)
Cap. Flow
+$8.89B
Cap. Flow
% of AUM
8.09%
Top 10 Holdings %
Top 10 Hldgs %
35.27%
Holding
3,643
New
809
Increased
972
Reduced
1,047
Closed
744
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.35B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.85B |
| 3 |
Eli Lilly
LLY
|
+$999M |
| 4 |
Coca-Cola
KO
|
+$685M |
| 5 |
Broadcom
AVGO
|
+$616M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.12B |
| 3 |
Netflix
NFLX
|
+$678M |
| 4 |
Boston Scientific
BSX
|
+$671M |
| 5 |
Cencora
COR
|
+$627M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Consumer Discretionary | 12.77% |
| 3 | Healthcare | 10.45% |
| 4 | Financials | 7.74% |
| 5 | Communication Services | 5.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
X4 Pharmaceuticals
XFOR
$424M
| $322K | ﹤0.01% |
+80,456
| New | +$292K |
|
2402
PUT
Lyft
LYFT
$6.64B
| $322K | ﹤0.01% |
16,600
| – | – |
|
2403
CALL
QuantumScape Corp
QS
$3.9B
| $318K | ﹤0.01% |
30,500
+18,100
| +146% | +$250K |
|
|
IRD
2404
Opus Genetics
IRD
$323M
| $317K | ﹤0.01% |
+157,648
| New | +$320K |
|
2405
Sight Sciences
SGHT
$427M
| $317K | ﹤0.01% |
+39,953
| New | +$255K |
|
2406
PUT
Invesco CurrencyShares Japanese Yen Trust
FXY
$426M
| $317K | ﹤0.01% |
5,400
+300
| +6% | +$17.9K |
|
2407
Woori Financial
WF
$17.1B
| $315K | ﹤0.01% |
+5,356
| New | +$298K |
|
2408
W&T Offshore
WTI
$575M
| $314K | ﹤0.01% |
192,504
+165,001
| +600% | +$317K |
|
|
DTCX
2409
Datacentrex Inc
DTCX
$75M
| $314K | ﹤0.01% |
114,096
-10,800
| -9% | -$45.9K |
|
|
EDN
2410
Edenor
EDN
$1.01B
| $314K | ﹤0.01% |
10,467
-27,203
| -72% | -$757K |
|
2411
CI&T Inc
CINT
$468M
| $313K | ﹤0.01% |
76,930
-149,708
| -66% | -$681K |
|
2412
PJT Partners
PJT
$4.48B
| $313K | ﹤0.01% |
1,871
-1,824
| -49% | -$312K |
|
2413
Fabrinet
FN
$18.8B
| $311K | ﹤0.01% |
+684
| New | +$298K |
|
2414
Tidewater
TDW
$4.54B
| $311K | ﹤0.01% |
+6,155
| New | +$325K |
|
2415
CION Investment
CION
$372M
| $310K | ﹤0.01% |
+32,012
| New | +$309K |
|
2416
Option Care Health
OPCH
$3.61B
| $309K | ﹤0.01% |
+9,695
| New | +$285K |
|
|
CPRX
2417
DELISTED
Catalyst Pharmaceutical
CPRX
| $309K | ﹤0.01% |
13,227
-10,876
| -45% | -$242K |
|
2418
Newmark Group
NMRK
$2.62B
| $309K | ﹤0.01% |
+17,800
| New | +$312K |
|
2419
Cadeler
CDLR
$2.24B
| $308K | ﹤0.01% |
16,588
-84,581
| -84% | -$1.58M |
|
2420
Element Solutions
ESI
$9.17B
| $307K | ﹤0.01% |
12,290
-18,628
| -60% | -$484K |
|
2421
PUT
F5
FFIV
$23.4B
| $306K | ﹤0.01% |
+1,200
| New | +$323K |
|
2422
Churchill Downs
CHDN
$6.18B
| $306K | ﹤0.01% |
2,686
-3,129
| -54% | -$325K |
|
|
SLNO
2423
DELISTED
Soleno Therapeutics
SLNO
| $305K | ﹤0.01% |
6,595
-177,633
| -96% | -$9.74M |
|
|
BRT
2424
BRT Apartments
BRT
$266M
| $304K | ﹤0.01% |
+20,648
| New | +$305K |
|
2425
W.R. Berkley
WRB
$26B
| $297K | ﹤0.01% |
4,233
-1,812
| -30% | -$134K |
|
Similar funds
Marshall Wace's Q4 2025 Portfolio in Review
As of Q4 2025, Marshall Wace held 3,643 positions worth $110B, up 11% from $98.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $8.89B of net new capital in Q4 2025, opening 809 new positions and adding to 972 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $1.38B trimmed.
- Marshall Wace's largest Q4 2025 buy was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $3.35B increase.
- Marshall Wace's biggest Q4 2025 reduction was Microsoft, cutting an estimated $1.38B.
- Marshall Wace fully exited Ares Management in Q4 2025, selling an estimated $146M.
- Marshall Wace's ten largest holdings make up 35% of its $110B portfolio in Q4 2025.
- Marshall Wace opened 809 new positions and closed 744 in Q4 2025.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $110B.
Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.